US Patent 12,357,586 — assignment history and current owner

US 12,357,586 · Application 17/585,415

Use Of The Phytocannabinoid Cannabidiol (cbd) In Combination With A Standard Anti-epileptic Drug (saed) In The Treatment Of Epilepsy

Who owns US Patent 12,357,586?

US12357586 ("Use Of The Phytocannabinoid Cannabidiol (cbd) In Combination With A Standard Anti-epileptic Drug (saed) In The Treatment Of Epilepsy") — current assignee: JAZZ PHARMACEUTICALS OPERATIONS UK LIMITED. Status: Active, estimated expiration January 3, 2032. 5 recorded USPTO assignments.

Based on recorded USPTO assignment data, the apparent operating assignee of US Patent 12,357,586 is JAZZ PHARMACEUTICALS OPERATIONS UK LIMITED. Based on the most recent name change record (recorded 2025-04-11).

Patent title
Use Of The Phytocannabinoid Cannabidiol (cbd) In Combination With A Standard Anti-epileptic Drug (saed) In The Treatment Of Epilepsy
Application number
17/585,415
Apparent operating assignee
JAZZ PHARMACEUTICALS OPERATIONS UK LIMITED
Patent status
Active, estimated expiration January 3, 2032
Recorded assignments
5

Note: a security interest appears active (U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE) with no recorded release. Security interests reflect financing arrangements, not operating ownership.

Recorded assignment history

ExecutedRecordedConveyanceAssignor(s)Assignee(s)Reel/frame
Feb 7, 2023May 12, 2023Ownership TransferOTSUKA PHARMACEUTICAL CO., LTD.GW PHARMA LTD.63631/588
Dec 2, 2011Aug 11, 2023Ownership TransferSTEPHENS, GARY; WHALLEY, BEN; WILLIAMS, CLAIREGW PHARMA LIMITED; OTSUKA PHARMACEUTICAL CO. LIMITED64567/274
Jul 24, 2024Jul 26, 2024Security AgreementCAVION, INC.; CELATOR PHARMACEUTICALS, INC.; GW PHARMA LIMITED; JAZZ PHARMACEUTICALS IRELAND LIMITED; JAZZ PHARMACEUTICALS RESEARCH UK LIMITED (F/K/A GW RESEARCH LIMITED); JAZZ PHARMACEUTICALS, INC.U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE68173/155
Nov 20, 2023Jan 21, 2025Name ChangeGW RESEARCH LIMITEDJAZZ PHARMACEUTICALS RESEARCH UK LIMITED69945/331
Sep 12, 2024Apr 11, 2025Name ChangeGW PHARMA LIMITEDJAZZ PHARMACEUTICALS OPERATIONS UK LIMITED70817/264

Scrolls sideways on narrow screens

Chain of title

In 2023, OTSUKA PHARMACEUTICAL CO., LTD. assigned the patent to GW PHARMA LTD.. The most recent ownership transfer, recorded in 2023, lists GW PHARMA LIMITED; OTSUKA PHARMACEUTICAL CO. LIMITED as assignee. In 2025, GW PHARMA LIMITED changed its name to JAZZ PHARMACEUTICALS OPERATIONS UK LIMITED. In 2024, U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE recorded a security interest; this reflects a financing arrangement, not a change in operating ownership.

Apparent recorded rights summary — disclaimer

This tool presents recorded assignment data from the USPTO assignment database. It does not constitute a legal opinion on ownership or title. Assignments may exist that have not been recorded. Corrective records, off-record transfers, court orders, and other events may affect actual ownership. Consult a qualified patent attorney for definitive title analysis.

Ownership settled? Give your AI the file.

Application 17/585,415 · US 12,357,586

The recorded chain of title is one part of the record. PatentReply compiles the rest of US 12,357,586, from the claims as filed to the last action, for Claude, ChatGPT, Grok, or another supported AI client.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Data sourced from public USPTO assignment records. This tool provides informational summaries and should not be relied upon as legal advice or a definitive title opinion. Always verify patent ownership independently, especially where unrecorded transfers, court orders, or other off-record events may apply.